Effectiveness of steroid treatment in myasthenia gravis: a retrospective study
- 1 July 1991
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 84 (1) , 33-39
- https://doi.org/10.1111/j.1600-0404.1991.tb04899.x
Abstract
The records of 142 patients with generalized autoimmune myasthenia gravis who had been treated with steroids as the single immunosuppressive agent, collected at regular intervals, were employed for a retrospective evaluation. The effectiveness of treatment was assessed after 24 months; the data from the 6th and 12th months were also considered. After 24 months. 63.4% of the whole sample had improved (33.8% were in clinical or pharmacological remission); 13.4% were unchanged or had worsened and 22.3% had moved to a different immunosuppressive treatment. The rate of positive outcome was higher in patients over the age of 40 at disease onset.Keywords
This publication has 4 references indexed in Scilit:
- The relationship of age to outcome in myasthenia gravisNeurology, 1990
- Myasthenia gravis treatment: twelve years experience on 110 patientsThe Italian Journal of Neurological Sciences, 1987
- Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 PatientsAnnals of Neurology, 1984
- Myasthenia gravisNeurology, 1984